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OBJECTIVES We report on a previously unrecognized form of the long QT syndrome (QT interval
prolongation and pause-dependent polymorphic ventricular tachycardia [VT]) entirely related
to myocardial infarction (MI).
BACKGROUND Polymorphic VT in the setting of acute MI generally occurs during the hyperacute phase, is
related to ischemia, and is not associated with QT prolongation. Although QT prolongation
after MI is well described, typical pause-dependent polymorphic VT (torsade de pointes)
secondary to uncomplicated MI was previously unknown.
METHODS Of 434 consecutive admissions for acute MI, 8 patients had progressive QT prolongation that
led to typical torsade de pointes. None of these patients had active ischemia or other known
causes of QT prolongation. These patients were compared with 100 consecutive patients with
uncomplicated MI who served as controls.
RESULTS The incidence of torsade de pointes following MI was 1.8% (95% confidence interval 0.8% to
3.6%). The QTc intervals of patients and controls were similar on admission. The QTc
lengthened by day 2 in both groups, but more so in patients with torsade de pointes (from
470 6 46 to 492 6 57 ms [p , 0.05] and from 445 6 58 to 558 6 84 ms, respectively [p ,
0.01]). Maximal QT prolongation and torsade de pointes occurred 3 to 11 days after
infarction. Therapy included defibrillation, magnesium, lidocaine and beta-blockers. Three
patients required rapid cardiac pacing. The long-term course was uneventful.
CONCLUSIONS Infarct-related torsade de pointes is uncommon but potentially lethal. An acquired long QT
syndrome should be considered in patients recovering from MI who experience polymorphic
VT as specific therapeutic measures are mandatory. (J Am Coll Cardiol 2001;38:1168–74)
© 2001 by the American College of Cardiology
Torsade de pointes is a polymorphic ventricular tachycardia
(VT) associated with a long QT syndrome (LQTS) (1). In
its most typical form, sudden slowing of heart rate (i.e.,
pauses) invariably precede each burst of torsade de pointes,
and the recurrent arrhythmia is referred to as “pause-
dependent torsade de pointes” (2–4). The long QT reflects
a delay in myocardial repolarization caused by malfunction-
ing ion channels. This ion-channel malfunction may be due
to mutations in the genes that encode these channels (in the
congenital LQTS) or may be caused by medications, met-
abolic abnormalities, sympathetic imbalance, or brady-
arrhythmias (in the acquired LQTS) (1).
We describe typical pause-dependent torsade de pointes
following excessive QT prolongation in patients recovering
from an otherwise uncomplicated myocardial infarction
(MI). The QT prolongation after MI is a well-described
phenomenon that adversely affects prognosis (5,6). How-
ever, to the best of our knowledge, this is the first series
describing a LQTS (i.e., QT prolongation and torsade de
pointes) related solely to MI.
METHODS
From May 1999 to May 2000, a total of 434 patients were
hospitalized in our intensive cardiac care unit with acute
MI. Eight (1.8% [95% confidence interval 0.8% to 3.6%]) of
these cases were prospectively diagnosed as infarct-related
LQTS because all the following criteria were met: 1) an
acute MI was diagnosed clinically and was confirmed by
serial electrocardiograms (ECGs) (showing new ST-
segment deviation or new Q-waves) and by serial blood tests
(showing high creatine kinase and creatine kinase-MB
fraction or troponin-I levels); 2) spontaneous pause-
dependent torsade de pointes (1–4) was documented during
obvious QT prolongation (Fig. 1); 3) other causes of the
LQTS (including medications known to affect repolariza-
tion, bradyarrhythmias, or metabolic abnormalities) (1)
were excluded or considered highly unlikely (see the follow-
ing text); and 4) a congenital LQTS was also considered
unlikely because of the age at presentation and the medical
history.
One hundred consecutive patients hospitalized in 1999
with MI (who were in sinus rhythm, had no bundle branch
block and were not receiving drugs that prolong repolariza-
tion) were retrospectively included as a control group. The
following ECGs were analyzed: 1) the admission ECG
(generally during the hyperacute phase of infarction); 2) the
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first ECG showing resolution of the acute ST changes
(within 24 to 48 h of admission); 3) the trace showing
maximal QT prolongation; and 4) the discharge ECG. All
ECGs were recorded using standard gain (10 mm/mV) and
speed (25 mm/s). The QT interval was defined as the
interval between the onset of the QRS and the end of the T
wave (defined as the return of the T wave to the baseline or
the nadir between the T wave and the U wave when these
were separated). The QT interval was measured in all 12
leads and analysis was done both for the longest QT and for
the average QT of all the 12 leads. The QT values were
“corrected for heart rate” using the Bazett formula [QTc 5
QT/(RR)1/2].
Statistical analysis. All variables are expressed as mean 6
SD. Time-related changes in QTc were analyzed by either
one- or two-way analysis of variance for repeated measures,
using the Newman-Keuls test for multiple comparisons. All
analyses were done using GB-Stat software, version 6.5
(Dynamic Microsystems, Silver Springs, Maryland).
RESULTS
Study population. Eight patients (4 men, 4 women) aged
73 6 13 years (range 47 to 88 years) developed marked QT
prolongation and torsade de pointes following an MI
(Q-wave anterior MI in 4 patients, inferior MI in 2 patients
and non–Q-wave infarction in 2 patients). Their left ven-
tricular ejection fraction was 42 6 11% (range 28% to 56%).
One of these patients had a previous infarction and two had
previous coronary bypass surgery, including one with peri-
operative infarction. All had hypertension, and one patient
had asthma and diabetes. Only one patient (a 71-year-old
woman) reported a previous syncopal episode (at the age of
69 years) and none had a familial history of sudden death,
syncope or LQTS. Treatment on admission included
thrombolytic therapy in two patients and primary angio-
plasty in one.
The control group included 100 patients (76% men),
aged 62 6 12 years, with Q-wave infarction in 78% (half of
them in the anterior wall). Acute reperfusion therapy was
given to 44% of patients. Their left ventricular ejection
fraction was 0.56 6 0.16. Both groups (“patients” and
Abbreviations and Acronyms
EAD 5 early after depolarization
ECG 5 electrocardiogram/electrocardiographic
LAD 5 left anterior descending
LQTS 5 long QT syndrome
MI 5 myocardial infarction
VF 5 ventricular fibrillation
VT 5 ventricular tachycardia
Figure 1. Electrocardiogram (leads V1 through V6) of an 82-year-old woman who developed torsade de pointes three days after anterior myocardial
infarction. The QT is normal on admission (QTc 5 418 ms), increases by day 2 (QTc 5 598 ms), reaches a maximal duration on day 3 (QTc 5 645 ms)
and normalizes by day 10 (QTc 5 430 ms).
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“controls”) were similar in terms of gender, age, and left
ventricular ejection fraction.
Prolongation of QT following MI. The QTc of patients
and controls was similar on the day of admission for MI
(Fig. 2). The QTc lengthened significantly by day 2 in both
groups, but far more in patients with torsade de pointes
(from 470 6 46 to 492 6 57 ms in the control group [p ,
0.05] and from 445 6 58 to 558 6 84 ms in patients with
torsade de pointes [p , 0.01]). The QTc subsequently
shortened in the control group but continued to lengthen
during days 3 to 10 in the torsade de pointes group (Fig. 2).
Torsade de pointes following MI. The maximal QT
prolongation and QT-related arrhythmias occurred 3 days
(4 patients) and 6 to 11 days (4 patients) after the onset of
MI. Other than mild transient heart failure on admission in
two patients, the hospital course was uncomplicated until
the occurrence of torsade de pointes. Specifically, none of
the eight patients had ventricular arrhythmias during the
hyperacute phase, and none had bradyarrhythmias, recur-
rent angina or reinfarction at any time during hospitaliza-
tion. Moreover, on the day of torsade de pointes and
between recurrent arrhythmias, none had clinical or ECG
evidence of acute ischemia. Medications prescribed before
the onset of torsade de pointes included aspirin (7 patients),
heparin (5 patients), nitrates or angiotensin-converting
enzyme inhibitors (3 patients each), verapamil, statins (2
patients), and insulin and inhaled bronchodilators (1 pa-
tient). Of note, four patients were receiving beta-blockers
when torsade de pointes occurred. Although three patients
received a diuretic (furosemide), none had hypokalemia or
hypomagnesemia (potassium serum levels in the low normal
range [K 5 3.8 mEq/l] were measured in two patients).
Finally, one patient was receiving amiodarone, which was
started three years earlier for atrial fibrillation and continued
at a stable oral dosage of 200 mg/day. The sequence of
events, with numerous arrhythmic episodes documented
three days after hospitalization, suggested that the MI
played the main role in triggering the arrhythmias. There-
fore, amiodarone was not discontinued.
Coronary anatomy. Five patients underwent coronary an-
giography and all but one had single-vessel disease. Three of
them had catheterization twice: before and after QT pro-
longation. The first patient (Fig. 3) had subtotal occlusion
of a small diagonal branch in the initial catheterization and
this was treated conservatively. He had the same findings
when QT prolongation and recurrent ventricular fibrillation
(VF) (one week later) prompted catheterization again. The
second patient (lower panel in Fig. 4) underwent angio-
plasty of an occluded left anterior descending coronary
artery on admission. However, torsade de pointes deterio-
rating to VF occurred on day 6 and again on day 8. This
prompted a second catheterization, which revealed that the
dilated vessel was patent. The third patient underwent
coronary bypass surgery following the acute occlusion of a
stent in the left anterior descending (LAD) coronary artery
and had a perioperative anterior infarction. A week later he
had recurrent torsade de pointes and VF. Repeated cathe-
terization revealed that the LAD was still occluded and the
arterial graft was still patent.
Two additional patients underwent catheterization only
after torsade de pointes documentation. In one of them,
angioplasty of an occluded right coronary artery had no
noticeable effects on the prolonged QT. The second patient
had an occluded right coronary artery with good collateral
flow and was treated conservatively.
Mode of onset. At the time of maximal QT prolongation
and torsade de pointes, all patients had stable, deep, inverted
T-waves (Figs. 1, 3 and 4). All the arrhythmias evolved
from sinus rhythm (rate 72 6 8 beats/min). All episodes of
torsade de pointes ($2 arrhythmias/patient) were pause-
dependent. The pauses triggering the arrhythmias were
postextrasystolic pauses (Figs. 3 and 4). These pauses lasted
1,170 6 200 ms. The coupling interval of the extrasystole
initiating torsade de pointes was 514 6 120 ms.
Acute and long-term therapy. Four patients required di-
rect current shock for terminating torsade de pointes that
deteriorated to VF. In addition, treatment of torsade de
pointes included intravenous magnesium (7 patients), lido-
caine (6 patients) and incremental dosages of beta-blockers
(in all but the patient with asthma). Nevertheless, three
patients required emergency transvenous cardiac pacing for
recurrent drug-refractory torsade de pointes, including two
patients with recurrent VF. The QT interval spontaneously
Figure 2. QTc values (according to the longest QT of all 12 leads) in
patients with torsade de pointes following myocardial infarction (black
bars) and controls with uncomplicated myocardial infarction (white bars).
Day 1: QTc during the hyperacute phase of the infarction. Day 2: QTc
following resolution of ST changes. Days 3 to 10: QTc recorded during
the day of torsade de pointes (patient group) or in the trace showing the
longest QT during days 3 to 10 (controls). Discharge: The QTc at the
time of hospital discharge (days 8 to 19). The QTc significantly increased
in the controls by day 2 but notably more so in patients who eventually
developed torsade de pointes: *p , 0.05; **p , 0.01. The QTc values
derived from the mean QT of all the 12 leads gave similar differences
among the groups (not shown).
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shortened within 10 days of the MI in three of the patients
with torsade de pointes (Fig. 1). These patients were
discharged on a drug regimen that included beta-blockers
and were instructed to avoid all medications that prolong
repolarization. In the remaining patients, the QT was still
prolonged at the time of the scheduled hospital discharge.
These patients underwent implantation of a dual-chamber
pacemaker (2 patients) or defibrillator (2 patients) equipped
with a pause-prevention pacing algorithm (7). Device pro-
gramming included features to prevent torsade de pointes as
described elsewhere (7). Amiodarone was later prescribed to
one patient with an implanted pacemaker because of fre-
quent episodes of atrial fibrillation.
All the eight patients remained asymptomatic during a
mean follow-up period of 16 6 5 months. Repeated Holter
recordings and periodic interrogation of the implanted
devices failed to reveal any arrhythmias after hospital dis-
charge. The QTc interval recorded three months after
hospital discharge was ,450 ms in all but the two patients
treated with amiodarone.
DISCUSSION
Polymorphic ventricular arrhythmias (polymorphic VT [8]
and VF [9]) related to an acute MI generally strike during
the hyperacute phase, are clearly related to ischemia and are
not associated with a long QT (8,10). In contrast, we
describe polymorphic VT during the “healing phase” of MI
in patients with no evidence of ongoing ischemia and
following excessive QT prolongation. The marked changes
in the QT morphology noted after pauses (Fig. 4), the long
coupling interval of the extrasystoles triggering torsade de
pointes, and the mode of onset of the arrhythmias (follow-
ing a “short-long-short” sequence [Figs. 3 and 4]) support
the diagnosis of “pause-dependent torsade de pointes due to
a LQTS” in our patients. In the absence of identifiable
causes of LQTS, we propose the term “infarct-related
LQTS” to describe this phenomenon.
Main findings. In this case-control study, the QT interval
generally increased during the course of an MI (Fig. 2). In
agreement with previous studies (11–13), the QT prolon-
gation was significant but transient, reaching a maximal
level within days of an MI and shortening to the initial
values by the 10th day in most patients. During this
transient QT prolongation, however, eight patients devel-
oped all the features characteristic of a LQTS. These
patients had QT intervals that were similar to those of the
control group on admission but prolonged excessively after-
wards. Although these giant QT intervals eventually nor-
malized, malignant arrhythmias typical of torsade de pointes
occurred 3 to 10 days after the infarction.
We cannot rule out a role for ischemia in the genesis of
the arrhythmias observed. However, patients with multiple
episodes of torsade de pointes had no clinical, ECG or (in
5 patients) angiographic findings to suggest that either acute
ischemia or reinfarction was responsible for these particular
arrhythmias. In fact, early appearance of deeply inverted,
large T-waves (of the magnitude seen in our patients) has
been correlated with effective reperfusion (14–16). More-
over, the similarities between the arrhythmias recorded in
our patients and those reported in other forms of the LQTS
(2–4) suggest a similar underlying mechanism not neces-
sarily related to acute ischemia (see the following text).
Figure 3. A 47-year-old man with infarct-related long QT syndrome. Day 1: Acute anterior infarction treated with streptokinase. Peak creatine kinase 5
600 U/l (QTc 5 450 ms). Day 2: Partial resolution of ST-elevation (QTc 5 450 ms). Day 7: Inverted T-waves have developed (QTc 5 469 ms).
Catheterization showed subtotal occlusion of a small diagonal branch (treated conservatively). Day 9: Cardiac arrest with ventricular fibrillation (VF). Giant
inverted T-waves are evident (QTc 5 540 ms). Repeated cardiac catheterization showed no changes. Day 11: Recurrent pause-dependent torsade de pointes
despite beta-blockers and magnesium. Note the “short-long-short” initiating sequence (S 5 short cycle; L 5 long cycle). Day 60: The QT interval two
months after the infarct is normal (QTc 5 400 ms).
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Probable mechanism of infarct-related LQTS. In any
LQTS (congenital or acquired), arrhythmias occur because:
First, prolongation of the action potential affects voltage-
dependent calcium-channels, causing a surplus of positive
ions that creates early after depolarizations (EADs). Even-
tually, these EADs reach threshold amplitude and trigger
ventricular extrasystoles (1). Second, cells in the mid-
myocardium, with electrophysiologic properties similar to
Purkinje fibers, display longer action potentials and more
EADs than epicardial or endocardial cells (17). The result-
ant heterogeneity of repolarization allows the propagation of
multiple waves of reentry responsible for torsade de pointes
(18).
Similar conditions may develop during the healing phases
of an MI: 1) The action potential of Purkinje fibers (which
initially shortens during prolonged ischemia) not only nor-
malizes during a recovery period, but also increases over a
control value (19). This action-potential prolongation often
leads to EADs and to triggered arrhythmias in infarct
models (19). 2) The difference in the refractory period
between adjacent areas in the ventricle is maximal a few days
after an MI and normalizes within weeks (20). According to
these experiments, the odds for torsade de pointes should be
maximal within days of an infarct, as observed in our
patients. Third, as in other forms of LQTS (2,4), torsade de
pointes after MI was preceded by “short-long-short” cycles.
Such oscillations in cycle length may potentiate calcium-
loading (21) (triggering further extrasystoles), while increas-
ing the dispersion of repolarization by predominantly in-
creasing the action potential in ischemic myocardium
(facilitating re-entry) (22).
Rather than originating from the infarcted zone, QT
prolongation could be related to a compensatory hypertro-
phy (remodeling) of noninfarcted zones in the left ventricle.
After all, action-potential prolongation in hypertrophic
myocytes is a universal consequence of hypertrophy, regard-
less of its cause (23). In a rat model of MI, down-regulation
of potassium channel gene expression and potassium cur-
rents (with consequent action potential prolongation and
EADs) occurs in noninfarcted zones of the left ventricle as
early as three days after MI, long before the morphologic
changes of hypertrophy can be identified (24). The striking
T-wave changes seen in our patients also deserve comment.
Very recent data (25) suggest that such giant and bizarre
T-wave changes may result from combined blockade of
both IKr and Iks currents. Interestingly, reduction of the
messenger RNA (mRNA) levels—and consequently, of the
channel subunits that form IKr and Iks channels—can
Figure 4. (Top) An 85-year-old man (Patient 2) with anterior infarction treated with tissue plasminogen activator. Day 1: Obvious ST elevation in the
precordial leads (QTc 5 440 ms). Day 2: Early appearance of giant inverted T-waves. (QT 5 600 ms; QTc 5 674 ms). Day 3: Brief burst of
pause-dependent torsade de pointes. (Bottom) A 67-year-old man (Patient 3) with anterior infarction treated with primary angioplasty of the left anterior
descending coronary artery. He had an uncomplicated course until day 6 but then had recurrent torsade de pointes deteriorating to ventricular fibrillation.
Spontaneous termination of torsade de pointes is shown on the eighth day. Note the QT augmentation following the pause (arrowheads).
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occur in the layer of epicardium surviving around an
endocardial infarcted zone (26). Alternatively, the patchy
sympathetic denervation that often follows MI (27) could
have contributed to the QT prolongation and arrhythmo-
genesis in our patients (28). This could explain why the QT
morphology (with giant inverted T-waves) in our patients is
similar to that observed when unilateral nervous system
disease (29) or pathologies causing “sympathetic imbalance”
(1,30) are the basis of an acquired LQTS.
Previous studies. Ischemic polymorphic VT, which has
been the focus of previous studies (8,31,32), differs from
infarct-related torsade de pointes in terms of pathophysiol-
ogy and ECG manifestations. During ischemia, the exces-
sive dispersion of repolarization is due to uneven shortening
of the action potential in different myocardial layers (33).
This enables reentrant arrhythmias during the very early
phases of repolarization. Consequently, “ischemic polymor-
phic VT” is triggered by extrasystoles with very short
coupling interval (the “R-on-T” phenomenon) and is not
pause-dependent (8,10). Some investigators have used the
term “torsade de pointes” to describe polymorphic arrhyth-
mias during MI (31,34). However, the available illustrations
suggest that the majority of the patients in these studies had
(short QT) “ischemic polymorphic VT.”
Study limitations. First, documentation of torsade de
pointes was required for inclusion in our series. However, it
is possible that short asymptomatic arrhythmias were missed
in additional patients because torsade de pointes tends to
occur when ECG monitoring is less rigorous (.48 h after
hospitalization). Thus, it is possible that we underestimated
the incidence of infarct-related LQTS. Second, amiodarone
could have contributed to the arrhythmia in one patient.
Moreover, the list of nonantiarrhythmic drugs that prolong
repolarization (by means of potassium-channel blockade)
keeps expanding (35), and it is possible that drugs that are
now considered safe and were received by our patients will
prove to be potassium-channel blockers in the future. Third,
a congenital LQTS would be an unlikely explanation for
torsade de pointes first presenting at the age of 73 6
13 years (36). However, both “mild mutations” (37) and
genetic polymorphism (38) becoming clinically apparent
when challenged by the repolarization abnormalities im-
posed by an MI are possible.
Clinical implications. QT prolongation after infarction is
common (6,11–13), whereas infarct-related LQTS is rare,
yet potentially lethal. Careful monitoring of patients in
whom the QT interval fails to shorten prior to hospital
discharge is probably wise. Detection of “warning signs” for
torsade de pointes, like postextrasystolic QT changes (1,3),
should call for further caution. It is important to recognize
this syndrome of “postinfarction LQTS” as this form of
“late VF” (occurring .48 h after MI) may not necessarily
require implantation of an automatic defibrillator. Although
it is impossible to assess the contribution of long-term
cardiac pacing to the noneventful course in our patients,
their benign long-term course is reassuring.
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